Similarly, amplifications of MYC, BRCA2, and a co‐amplification of the region PDGFRA–KIT occurred mostly in recurring tumors (P1, P2, P4, P6, P7, P10), whereas JUN and APC mutations occurred in a single osteosarcoma primary (P1). Here, BRCA2 is linked to osteosarcoma.